Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposure

Microbial Drug Resistance

Volumn 12, Issue 1, 2006, Pages 23-28

  Samore, Matthew H ^a,b   Venkataraman, Lata ^c   Degirolami, Paola C ^c   Merrigan, Michelle M ^d   Johnson, Stuart ^e   Gerding, Dale N ^e   Carmeli, Yehuda ^c,f   Harbarth, Stephan ^g  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TROVAFLOXACIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BRUCELLA; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG EXPOSURE; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING; UNITED STATES;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHENOTYPE;

BACTERIA (MICROORGANISMS); BRUCELLA; CLOSTRIDIUM DIFFICILE;

EID: 33646041878     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.12.23     Document Type: Article

References (32)

1. Ackermann, G., Y.J. Tang, R. Kueper, P. Heisig, A.C. Rodloff, J. Silva, and S.H. Cohen. 2001. Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob. Agents Chemother. 45:2348-2353.
2. Ackermann, G., A. Degner, S.H. Cohen, J. Silva, Jr., and A.C. Rodloff. 2003. Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. J. Antimicrob. Chemother. 51:599-603.
3. Ackermann, G., Y.J. Tang-Feldman, R. Schaumann, J.P. Henderson, A.C. Rodloff, J. Silva, and S.H. Cohen. 2003. Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile. Clin. Microbiol. Infect. 9:526-530.
4. Alonso, R. T., Pelaez, M. Gonzalez-Abad, L. Alcala, P. Munoz, M. Rodriguez-Creixems, and E. Bouza. 2001. In vitro activity of new quinolones against Clostridium difficile. J. Antimicrob. Chemother. 47:195-197.
5. Alonso, R., A. Martin, T. Pelaez, M. Marin, M. Rodriguez-Creixmens, and E. Bouza. 2005. An improved protocol for pulsed-field gel electrophoresis typing of Clostridium difficile. J. Med. Microbiol. 54:155-157.
6. Barbut, F., D. Deere, B. Burghoffer, D. Lesage, F. Delisle, V. Lalande, M. Delmee, V. Avesani, N. Sano, C. Coudert, and J.C. Petit. 1999. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob. Agents Chemother. 43:2607-2611.
7. Chow, A.W., N. Cheng, and K.H. Bartlett. 1985. In vitro susceptibility of Clostridium difficile to new beta-lactam and quinolone antibiotics. Antimicrob. Agents Chemother. 28:842-844.
8. Clabots, C.R., S. Johnson, K.M. Bettin, P.A. Mathie, M.E. Mulligan, D.R. Schaberg, L.R. Peterson, and D.N. Gerding. 1993. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J. Clin. Microbiol. 31:1870-1875.
9. Clinical and Laboratory Standards Institute. 2005. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. Document M11-A6. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Drummond, L.J., J. McCoubrey, D.G. Smith, J.M. Starr, and I.R. Poxton. 2003. Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month period. J. Med. Microbiol. 52:259-263.
11. Gaynes, R., D. Rimland, E. Killum, H.K. Lowery, T.M. Johnson, G. Killgore, and F.C. Tenover. 2004. Outbreak of Clostridium difficile infection in a long-term care facility: Association with gatifloxacin use. Clin. Infect. Dis. 38:640-645.
12. Gerding, D.N. 1997. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin. Infect. Dis. 25(Suppl 2):S206-S210.
13. Gerding, D.N. 2004. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin. Infect. Dis. 38:646-648.
14. Harbarth, S., M.H. Samore, and Y. Carmeli. 2001. Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea. J. Hosp. Infect. 48:93-97.
15. Impallomeni, M., N.P. Galletly, S.J. Wort, J.M. Starr, and T.R. Rogers. 1995. Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. Br. Med. J. 311:1345-1346.
16. Johnson, S., and D.N. Gerding. 1998. Clostridium difficile-associated diarrhea. Clin. Infect. Dis. 26:1027-1034.
17. Johnson, S., M.H. Samore, K.A. Farrow, G.E. Killgore, F.C. Tenover, D. Lyras, J.I. Rood, P. DeGirolami, A.L. Baltch, M.E. Rafferty, S.M. Pear, and D.N. Gerding. 1999. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N. Engl. J. Med. 341:1645-1651.
18. Johnson, S., J. Sanchez, and D. Gerding. 2000. Metronidazole resistance in Clostridium difficile. Clin. Infect. Dis. 31:625-626.
19. Kristjansson, M., M.H. Samore, D.N. Gerding, P.C. DeGirolami, K.M. Bettin, A.W. Karchmer, and R.D. Arbeit. 1994. Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. J. Clin. Microbiol. 32:1963-1969.
20. McCusker, M.E., A.D. Harris, E. Perencevich, and M.C. Roghmann. 2003. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg. Infect. Dis. 9:730-733.
21. Noren, T., Y.J. Tang-Feldman, S.H. Cohen, J. Silva, Jr., and P. Olcen. 2002. Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn. Microbiol. Infect. Dis. 42:149-151.
22. Pear, S.M., T.H. Williamson, K.M. Bettin, D.N. Gerding, and J.N. Galgiani. 1994. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann. Intern. Med. 120:272-277.
23. Pituch, H., A. van Belkum, N. van den Braak, P. Obuch-Woszczatynski, A. Sawicka-Grzelak, H. Verbrugh, F. Meisel-Mikolajczyk, and M. Luczak. 2003. Clindamycin-resistant, toxin A-negative, toxin B-positive Clostridium difficile strains cause antibiotic-associated diarrhea among children hospitalized in a hematology unit. Clin. Microbiol. Infect. 9:903-904.
24. Sambol, S.P., M.M. Merrigan, J.K. Tang, S. Johnson, and D.N. Gerding. 2002. Colonization for the prevention of Clostridium difficile disease in hamsters. J. Infect. Dis. 186:1781-1789.
25. Samore, M.H. 1999. Epidemiology of nosocomial Clostridium difficile diarrhoea. J. Hosp. Infect. 43(Suppl):S183-S190.
26. Samore, M.H., K.M. Bettin, P.C. DeGirolami, C.R. Clabots, D.N. Gerding, and A.W. Karchmer. 1994. Wide diversity of Clostridium difficile types at a tertiary referral hospital. J. Infect. Dis. 170:615-621.
27. Samore, M.H., L. Venkataraman, P.C. DeGirolami, R.D. Arbeit, and A.W. Karchmer. 1996. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am. J. Med. 100:32-40.
28. Samore, M.H., G. Killgore, S. Johnson, R. Goodman, J. Shim, L. Venkataraman, S. Sambol, P. DeGirolami, F. Tenover, R. Arbeit, and D. Gerding. 1997. Multicenter typing comparison of sporadic and outbreak Clostridium difficile isolates from geographically diverse hospitals. J. Infect. Dis. 176:1233-1238.
29. Settle, C.D., M.H. Wilcox, W.N. Fawley, O.J. Corrado, and P.M. Hawkey. 1998. Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam. Aliment. Pharmacol. Ther. 12:1217-1223.
30. Shim, J.K., S. Johnson, M.H. Samore, D.Z. Bliss, and D.N. Gerding. 1998. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 351:633-636.
31. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
32. Wilcox, M.H., W. Fawley, J. Freeman, and J. Brayson. 2000. In vitro activity of new generation fluoroquinolones against genotypically distinct and indistinguishable Clostridium difficile isolates. J. Antimicrob. Chemother. 46:551-556.